OYAHIDA KHATUN

Virology enthusiast

[Shashank Tripathi @Shashank_IISc]

Coronaviruses are masters of evasion and inhibition of cellular innate immunity. Topic covered in depth in this review from our group.

https://t.co/ivK294GmLH

[Shashank Tripathi @Shashank_IISc]

Congratulations to @OyahidaK for successfully defending her thesis. Best wishes to her as she prepares to join @thechandalab.

[OYAHIDA KHATUN @OyahidaK]

@imtribhuwan @Shashank_IISc @evp_iisc @IISC Thanks

[OYAHIDA KHATUN @OyahidaK]

@ghoshgaurab2011 @Shashank_IISc @evp_iisc @IISC Thanks Gaurab

[OYAHIDA KHATUN @OyahidaK]

@nishicool1 @Shashank_IISc Thanks Nishi

[OYAHIDA KHATUN @OyahidaK]

@abandopa @Shashank_IISc @evp_iisc @IISC Thank you

[OYAHIDA KHATUN @OyahidaK]

@Sudha__Kumari @Shashank_IISc @evp_iisc @IISC Thanks ma'am

[OYAHIDA KHATUN @OyahidaK]

@joelpalpath @Shashank_IISc @evp_iisc @IISC Thanks Joel

[Shashank Tripathi @Shashank_IISc]

Congratulations to Oyahida Khatun, our lab's first graduating PhD student, on receiving the Sun Pharma Award for her doctoral research! 🎊🎉 @OyahidaK @evp_iisc @iisc

[Shashank Tripathi @Shashank_IISc]

Pleased to share this study from @evp_iisc on innate immune antagonism by SARS-CoV-2. Published in Cellular And Molecular Life Sciences @SpringerCellBio. Kudos to @OyahidaK leading this. https://t.co/enBXkbeqg2

[IISc Bangalore @iiscbangalore]

Congratulations to the faculty members selected as INSA Fellows and Associate Fellows 2023!

[IISc Bangalore @iiscbangalore]

New study by @evp_iisc @Shashank_IISc shows how several mutations accumulated through recombination in #SARSCoV2 viral proteins, allows the Omicron variants to escape from the host’s defenses and bind more tightly to the host cell. https://t.co/DzhMvuXRe8
#IIScresearch

[Shashank Tripathi @Shashank_IISc]

Very Busy ‘Open Day 2023’ for @evp_iisc lab at CIDR, IISc

[OYAHIDA KHATUN @OyahidaK]

I am excited to be giving invited talk at @OPTIONS XI in Belfast on Sept 26 and thankful to @isirv for the travel award. It won't be possible if UK Visa is not approved in time. @UKinIndia Please help me.
@UKinBengaluru @iiscbangalore @OIA_MEA @GOVUK

[Shashank Tripathi @Shashank_IISc]

In this preprint we report important observation of increased recombination in Omicron SARS-CoV-2 and its potential role in antibody escape.

https://t.co/C65kkTGrKS

[Shashank Tripathi @Shashank_IISc]

Grateful to @AmerSocVirol for the Global Scholar Award.

[Shashank Tripathi @Shashank_IISc]

Wishing all the best to @abhijith_biji as he moves to join Microbio PhD program in the @IcahnMountSinai, New York. As first undergrad student, he has set the bar high and we were lucky to have him in the lab. I know he is going to accomllish great feats and make us proud.

[Shashank Tripathi @Shashank_IISc]

Congratulations @OyahidaK

[Emerging Viral Pathogens Lab, CIDR, IISc @evp_iisc]

Congratulations @abhijith_biji for being awarded the "Best Oral Presentation" and for receiving the Travel Grant to attend the two-day International Conference on Coronaviruses held at @KashmirSkuast on May 10-11

Proud moment for EVP Lab 🥳🥳
@Shashank_IISc @iiscbangalore

[IISc Bangalore @iiscbangalore]

Montelukast, an FDA-approved asthma drug, can bind strongly and stably to a crucial #SARSCoV2 protein called Nsp1, and rescue inhibition of protein synthesis in immune cells, finds an @eLife study by IISc researchers
https://t.co/gVhUCdwE1z
#IIScresearch